Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.
Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS; Athena Breast Health Network Investigators and Advocate Partners; Esserman LJ. Wang T, et al. Among authors: keane h. NPJ Breast Cancer. 2024 Oct 14;10(1):90. doi: 10.1038/s41523-024-00681-z. NPJ Breast Cancer. 2024. PMID: 39397069 Free PMC article.
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.
Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ; Athena Breast Health Network Investigators and Advocate Partners; Esserman LJ. Huilgol YS, et al. Among authors: keane h. NPJ Breast Cancer. 2021 Aug 3;7(1):102. doi: 10.1038/s41523-021-00306-9. NPJ Breast Cancer. 2021. PMID: 34344894 Free PMC article.
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study.
Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS; Athena Breast Health Network Investigators and Advocate Partners; Esserman LJ. Wang T, et al. Among authors: keane h. Res Sq [Preprint]. 2023 May 10:rs.3.rs-2787493. doi: 10.21203/rs.3.rs-2787493/v1. Res Sq. 2023. Update in: NPJ Breast Cancer. 2024 Oct 14;10(1):90. doi: 10.1038/s41523-024-00681-z. PMID: 37214889 Free PMC article. Updated. Preprint.
Stromal lymphocytes are associated with upgrade of B3 breast lesions.
Kader T, Provenzano E, Jayawardana MW, Hendry S, Pang JM, Elder K, Byrne DJ, Tjoeka L, Frazer HM, House E, Jayasinghe SI, Keane H, Murugasu A, Rajan N, Miligy IM, Toss M, Green AR, Rakha EA, Fox SB, Mann GB, Campbell IG, Gorringe KL. Kader T, et al. Among authors: keane h. Breast Cancer Res. 2024 Jul 8;26(1):115. doi: 10.1186/s13058-024-01857-y. Breast Cancer Res. 2024. PMID: 38978071 Free PMC article.
Advancing Global Health Equity in Oncology Clinical Trial Access.
Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer; Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer. Bloomberg New Economy International Cancer Coalition, et al. Cancer Discov. 2024 Sep 24:OF1-OF7. doi: 10.1158/2159-8290.CD-24-1288. Online ahead of print. Cancer Discov. 2024. PMID: 39315831
60 results